English
简体中文
Total: £ 56.28
Published Date: 2025-06-19 | Pages: 98 | Tables: 104 | Pharma & Healthcare
The global market for Steroids APIs was valued at US$ 12484 million in the year 2024 and is projected to reach a revised size of US$ 19146 million by 2031, growing at a CAGR of 6.3% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Steroids APIs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Steroids API (Active Pharmaceutical Ingredient) refers to the key bioactive compounds used in the manufacturing of steroid-based medications, including corticosteroids, anabolic steroids, and sex hormones such as testosterone, estradiol, and progesterone. These APIs are produced through chemical synthesis or fermentation processes and are essential for treating a wide range of medical conditions, including inflammation, autoimmune diseases, hormonal imbalances, asthma, and certain cancers. As the core therapeutic component in formulations like tablets, injectables, creams, and inhalers, steroids APIs must meet strict regulatory standards for purity, potency, and safety set by authorities like the FDA and EMA.
Key market drivers for the Steroids API industry include the rising prevalence of chronic conditions such as asthma, arthritis, and hormonal disorders, which fuel demand for corticosteroids and sex hormone APIs. An aging global population is accelerating the use of estrogen, progesterone, and testosterone APIs for hormone replacement therapy, while the expanding generic drug market—particularly in developing countries—is boosting demand for cost-effective steroid formulations. Regionally, North America leads due to high prescription rates and strong CDMO activity, while Europe follows with a robust regulatory framework and established pharma manufacturers. India and China dominate bulk steroid API production, offering cost advantages and vast manufacturing capacity, whereas Latin America and Africa are emerging as new demand centers amid improving healthcare infrastructure and regulatory alignment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Steroids APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Steroids APIs.
The Steroids APIs market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Steroids APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Steroids APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Sanofi
GSK
Merck
Bayer
Teva
Cambrex
Olon
Axplora
Aspen API
Symbiotec
Lupin
Cipla
Ipca Laboratories
Henan Lihua
Hubei Gedian
Segment by Type
Corticosteroids APIs
Sex Hormone Steroids APIs
Segment by Application
Human Pharmaceuticals
Veterinary Medicine
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Steroids APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Steroids APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Steroids APIs Market Overview
1.1 Product Definition
1.2 Steroids APIs by Type
1.2.1 Global Steroids APIs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Corticosteroids APIs
1.2.3 Sex Hormone Steroids APIs
1.3 Steroids APIs by Application
1.3.1 Global Steroids APIs Market Value by Application (2024 VS 2031)
1.3.2 Human Pharmaceuticals
1.3.3 Veterinary Medicine
1.3.4 Others
1.4 Global Steroids APIs Market Size Estimates and Forecasts
1.4.1 Global Steroids APIs Revenue 2020-2031
1.4.2 Global Steroids APIs Sales 2020-2031
1.4.3 Global Steroids APIs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Steroids APIs Market Competition by Manufacturers
2.1 Global Steroids APIs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Steroids APIs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Steroids APIs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Steroids APIs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Steroids APIs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Steroids APIs, Product Type & Application
2.7 Global Key Manufacturers of Steroids APIs, Date of Enter into This Industry
2.8 Global Steroids APIs Market Competitive Situation and Trends
2.8.1 Global Steroids APIs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Steroids APIs Players Market Share by Revenue
2.8.3 Global Steroids APIs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Steroids APIs Market Scenario by Region
3.1 Global Steroids APIs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Steroids APIs Sales by Region: 2020-2031
3.2.1 Global Steroids APIs Sales by Region: 2020-2025
3.2.2 Global Steroids APIs Sales by Region: 2026-2031
3.3 Global Steroids APIs Revenue by Region: 2020-2031
3.3.1 Global Steroids APIs Revenue by Region: 2020-2025
3.3.2 Global Steroids APIs Revenue by Region: 2026-2031
3.4 North America Steroids APIs Market Facts & Figures by Country
3.4.1 North America Steroids APIs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Steroids APIs Sales by Country (2020-2031)
3.4.3 North America Steroids APIs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Steroids APIs Market Facts & Figures by Country
3.5.1 Europe Steroids APIs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Steroids APIs Sales by Country (2020-2031)
3.5.3 Europe Steroids APIs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Steroids APIs Market Facts & Figures by Region
3.6.1 Asia Pacific Steroids APIs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Steroids APIs Sales by Region (2020-2031)
3.6.3 Asia Pacific Steroids APIs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Steroids APIs Market Facts & Figures by Country
3.7.1 Latin America Steroids APIs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Steroids APIs Sales by Country (2020-2031)
3.7.3 Latin America Steroids APIs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Steroids APIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Steroids APIs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Steroids APIs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Steroids APIs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Steroids APIs Sales by Type (2020-2031)
4.1.1 Global Steroids APIs Sales by Type (2020-2025)
4.1.2 Global Steroids APIs Sales by Type (2026-2031)
4.1.3 Global Steroids APIs Sales Market Share by Type (2020-2031)
4.2 Global Steroids APIs Revenue by Type (2020-2031)
4.2.1 Global Steroids APIs Revenue by Type (2020-2025)
4.2.2 Global Steroids APIs Revenue by Type (2026-2031)
4.2.3 Global Steroids APIs Revenue Market Share by Type (2020-2031)
4.3 Global Steroids APIs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Steroids APIs Sales by Application (2020-2031)
5.1.1 Global Steroids APIs Sales by Application (2020-2025)
5.1.2 Global Steroids APIs Sales by Application (2026-2031)
5.1.3 Global Steroids APIs Sales Market Share by Application (2020-2031)
5.2 Global Steroids APIs Revenue by Application (2020-2031)
5.2.1 Global Steroids APIs Revenue by Application (2020-2025)
5.2.2 Global Steroids APIs Revenue by Application (2026-2031)
5.2.3 Global Steroids APIs Revenue Market Share by Application (2020-2031)
5.3 Global Steroids APIs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Steroids APIs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Steroids APIs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Steroids APIs Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Steroids APIs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Steroids APIs Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Steroids APIs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Cambrex
6.7.1 Cambrex Company Information
6.7.2 Cambrex Description and Business Overview
6.7.3 Cambrex Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cambrex Steroids APIs Product Portfolio
6.7.5 Cambrex Recent Developments/Updates
6.8 Olon
6.8.1 Olon Company Information
6.8.2 Olon Description and Business Overview
6.8.3 Olon Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Olon Steroids APIs Product Portfolio
6.8.5 Olon Recent Developments/Updates
6.9 Axplora
6.9.1 Axplora Company Information
6.9.2 Axplora Description and Business Overview
6.9.3 Axplora Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Axplora Steroids APIs Product Portfolio
6.9.5 Axplora Recent Developments/Updates
6.10 Aspen API
6.10.1 Aspen API Company Information
6.10.2 Aspen API Description and Business Overview
6.10.3 Aspen API Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Aspen API Steroids APIs Product Portfolio
6.10.5 Aspen API Recent Developments/Updates
6.11 Symbiotec
6.11.1 Symbiotec Company Information
6.11.2 Symbiotec Description and Business Overview
6.11.3 Symbiotec Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Symbiotec Steroids APIs Product Portfolio
6.11.5 Symbiotec Recent Developments/Updates
6.12 Lupin
6.12.1 Lupin Company Information
6.12.2 Lupin Description and Business Overview
6.12.3 Lupin Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lupin Steroids APIs Product Portfolio
6.12.5 Lupin Recent Developments/Updates
6.13 Cipla
6.13.1 Cipla Company Information
6.13.2 Cipla Description and Business Overview
6.13.3 Cipla Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Cipla Steroids APIs Product Portfolio
6.13.5 Cipla Recent Developments/Updates
6.14 Ipca Laboratories
6.14.1 Ipca Laboratories Company Information
6.14.2 Ipca Laboratories Description and Business Overview
6.14.3 Ipca Laboratories Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ipca Laboratories Steroids APIs Product Portfolio
6.14.5 Ipca Laboratories Recent Developments/Updates
6.15 Henan Lihua
6.15.1 Henan Lihua Company Information
6.15.2 Henan Lihua Description and Business Overview
6.15.3 Henan Lihua Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Henan Lihua Steroids APIs Product Portfolio
6.15.5 Henan Lihua Recent Developments/Updates
6.16 Hubei Gedian
6.16.1 Hubei Gedian Company Information
6.16.2 Hubei Gedian Description and Business Overview
6.16.3 Hubei Gedian Steroids APIs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Hubei Gedian Steroids APIs Product Portfolio
6.16.5 Hubei Gedian Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Steroids APIs Industry Chain Analysis
7.2 Steroids APIs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Steroids APIs Production Mode & Process Analysis
7.4 Steroids APIs Sales and Marketing
7.4.1 Steroids APIs Sales Channels
7.4.2 Steroids APIs Distributors
7.5 Steroids APIs Customer Analysis
8 Steroids APIs Market Dynamics
8.1 Steroids APIs Industry Trends
8.2 Steroids APIs Market Drivers
8.3 Steroids APIs Market Challenges
8.4 Steroids APIs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Steroids APIs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Steroids APIs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Steroids APIs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Steroids APIs Sales (Tons) of Key Manufacturers (2020-2025)
Table 5. Global Steroids APIs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Steroids APIs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Steroids APIs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Steroids APIs Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Steroids APIs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Steroids APIs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Steroids APIs, Product Type & Application
Table 12. Global Key Manufacturers of Steroids APIs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Steroids APIs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Steroids APIs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Steroids APIs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Steroids APIs Sales by Region (2020-2025) & (Tons)
Table 18. Global Steroids APIs Sales Market Share by Region (2020-2025)
Table 19. Global Steroids APIs Sales by Region (2026-2031) & (Tons)
Table 20. Global Steroids APIs Sales Market Share by Region (2026-2031)
Table 21. Global Steroids APIs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Steroids APIs Revenue Market Share by Region (2020-2025)
Table 23. Global Steroids APIs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Steroids APIs Revenue Market Share by Region (2026-2031)
Table 25. North America Steroids APIs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Steroids APIs Sales by Country (2020-2025) & (Tons)
Table 27. North America Steroids APIs Sales by Country (2026-2031) & (Tons)
Table 28. North America Steroids APIs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Steroids APIs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Steroids APIs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Steroids APIs Sales by Country (2020-2025) & (Tons)
Table 32. Europe Steroids APIs Sales by Country (2026-2031) & (Tons)
Table 33. Europe Steroids APIs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Steroids APIs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Steroids APIs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Steroids APIs Sales by Region (2020-2025) & (Tons)
Table 37. Asia Pacific Steroids APIs Sales by Region (2026-2031) & (Tons)
Table 38. Asia Pacific Steroids APIs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Steroids APIs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Steroids APIs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Steroids APIs Sales by Country (2020-2025) & (Tons)
Table 42. Latin America Steroids APIs Sales by Country (2026-2031) & (Tons)
Table 43. Latin America Steroids APIs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Steroids APIs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Steroids APIs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Steroids APIs Sales by Country (2020-2025) & (Tons)
Table 47. Middle East and Africa Steroids APIs Sales by Country (2026-2031) & (Tons)
Table 48. Middle East and Africa Steroids APIs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Steroids APIs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Steroids APIs Sales (Tons) by Type (2020-2025)
Table 51. Global Steroids APIs Sales (Tons) by Type (2026-2031)
Table 52. Global Steroids APIs Sales Market Share by Type (2020-2025)
Table 53. Global Steroids APIs Sales Market Share by Type (2026-2031)
Table 54. Global Steroids APIs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Steroids APIs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Steroids APIs Revenue Market Share by Type (2020-2025)
Table 57. Global Steroids APIs Revenue Market Share by Type (2026-2031)
Table 58. Global Steroids APIs Price (US$/Ton) by Type (2020-2025)
Table 59. Global Steroids APIs Price (US$/Ton) by Type (2026-2031)
Table 60. Global Steroids APIs Sales (Tons) by Application (2020-2025)
Table 61. Global Steroids APIs Sales (Tons) by Application (2026-2031)
Table 62. Global Steroids APIs Sales Market Share by Application (2020-2025)
Table 63. Global Steroids APIs Sales Market Share by Application (2026-2031)
Table 64. Global Steroids APIs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Steroids APIs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Steroids APIs Revenue Market Share by Application (2020-2025)
Table 67. Global Steroids APIs Revenue Market Share by Application (2026-2031)
Table 68. Global Steroids APIs Price (US$/Ton) by Application (2020-2025)
Table 69. Global Steroids APIs Price (US$/Ton) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Pfizer Steroids APIs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Sanofi Steroids APIs Product
Table 79. Sanofi Recent Developments/Updates
Table 80. GSK Company Information
Table 81. GSK Description and Business Overview
Table 82. GSK Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. GSK Steroids APIs Product
Table 84. GSK Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Merck Steroids APIs Product
Table 89. Merck Recent Developments/Updates
Table 90. Bayer Company Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Bayer Steroids APIs Product
Table 94. Bayer Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Teva Steroids APIs Product
Table 99. Teva Recent Developments/Updates
Table 100. Cambrex Company Information
Table 101. Cambrex Description and Business Overview
Table 102. Cambrex Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Cambrex Steroids APIs Product
Table 104. Cambrex Recent Developments/Updates
Table 105. Olon Company Information
Table 106. Olon Description and Business Overview
Table 107. Olon Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Olon Steroids APIs Product
Table 109. Olon Recent Developments/Updates
Table 110. Axplora Company Information
Table 111. Axplora Description and Business Overview
Table 112. Axplora Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Axplora Steroids APIs Product
Table 114. Axplora Recent Developments/Updates
Table 115. Aspen API Company Information
Table 116. Aspen API Description and Business Overview
Table 117. Aspen API Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Aspen API Steroids APIs Product
Table 119. Aspen API Recent Developments/Updates
Table 120. Symbiotec Company Information
Table 121. Symbiotec Description and Business Overview
Table 122. Symbiotec Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. Symbiotec Steroids APIs Product
Table 124. Symbiotec Recent Developments/Updates
Table 125. Lupin Company Information
Table 126. Lupin Description and Business Overview
Table 127. Lupin Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Lupin Steroids APIs Product
Table 129. Lupin Recent Developments/Updates
Table 130. Cipla Company Information
Table 131. Cipla Description and Business Overview
Table 132. Cipla Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. Cipla Steroids APIs Product
Table 134. Cipla Recent Developments/Updates
Table 135. Ipca Laboratories Company Information
Table 136. Ipca Laboratories Description and Business Overview
Table 137. Ipca Laboratories Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. Ipca Laboratories Steroids APIs Product
Table 139. Ipca Laboratories Recent Developments/Updates
Table 140. Henan Lihua Company Information
Table 141. Henan Lihua Description and Business Overview
Table 142. Henan Lihua Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 143. Henan Lihua Steroids APIs Product
Table 144. Henan Lihua Recent Developments/Updates
Table 145. Hubei Gedian Company Information
Table 146. Hubei Gedian Description and Business Overview
Table 147. Hubei Gedian Steroids APIs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 148. Hubei Gedian Steroids APIs Product
Table 149. Hubei Gedian Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Steroids APIs Distributors List
Table 153. Steroids APIs Customers List
Table 154. Steroids APIs Market Trends
Table 155. Steroids APIs Market Drivers
Table 156. Steroids APIs Market Challenges
Table 157. Steroids APIs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Steroids APIs
Figure 2. Global Steroids APIs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Steroids APIs Market Share by Type: 2024 & 2031
Figure 4. Corticosteroids APIs Product Picture
Figure 5. Sex Hormone Steroids APIs Product Picture
Figure 6. Global Steroids APIs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Steroids APIs Market Share by Application: 2024 & 2031
Figure 8. Human Pharmaceuticals
Figure 9. Veterinary Medicine
Figure 10. Others
Figure 11. Global Steroids APIs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Steroids APIs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Steroids APIs Sales (2020-2031) & (Tons)
Figure 14. Global Steroids APIs Average Price (US$/Ton) & (2020-2031)
Figure 15. Steroids APIs Report Years Considered
Figure 16. Steroids APIs Sales Share by Manufacturers in 2024
Figure 17. Global Steroids APIs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Steroids APIs Players: Market Share by Revenue in Steroids APIs in 2024
Figure 19. Steroids APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Steroids APIs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Steroids APIs Sales Market Share by Country (2020-2031)
Figure 22. North America Steroids APIs Revenue Market Share by Country (2020-2031)
Figure 23. United States Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Steroids APIs Sales Market Share by Country (2020-2031)
Figure 26. Europe Steroids APIs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Steroids APIs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Steroids APIs Revenue Market Share by Region (2020-2031)
Figure 34. China Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Steroids APIs Sales Market Share by Country (2020-2031)
Figure 42. Latin America Steroids APIs Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Steroids APIs Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Steroids APIs Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Steroids APIs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Steroids APIs by Type (2020-2031)
Figure 53. Global Revenue Market Share of Steroids APIs by Type (2020-2031)
Figure 54. Global Steroids APIs Price (US$/Ton) by Type (2020-2031)
Figure 55. Global Sales Market Share of Steroids APIs by Application (2020-2031)
Figure 56. Global Revenue Market Share of Steroids APIs by Application (2020-2031)
Figure 57. Global Steroids APIs Price (US$/Ton) by Application (2020-2031)
Figure 58. Steroids APIs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
